Investors
Financials
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 15, 2026 – Q1 2026 Sales
April 22, 2026 – 2025 Annual Results
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 9, 2026 – 2025 Annual Results
April 16, 2026 – Q1 2026 Sales
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
2024 Annual Financial Report
FY 2024 Results
Mauna Kea Technologies announces the opening of a safeguard proceeding to restructure its financial liabilities
Full Year 2024 Sales
Mauna Kea Technologies Announces its 2025 Financial Calendar
H1 2024 Financial Results and Q3 2024 Sales
Q2 2024 Sales
Publication of the 2023 Annual Financial Report
Full Year 2023 Results and Q1 2024 Sales
Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank
Mauna Kea Technologies Announces Initiation of Coverage by EuroLand Corporate
Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42% vs 2022
No results found.
News
Mauna Kea Technologies Reports Strong Q1 2026 Core Sales Growth
Mauna Kea Technologies Updates Its Financial Calendar
Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026
No results found.